PRGO Stock Summary and Trading Ideas (Perrigo Company PLC | NYSE:PRGO)

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Perrigo Company PLC trades on the NYSE stock market under the symbol PRGO.

As of March 16, 2026, PRGO stock price climbed to $9.72 with 3,885,402 million shares trading.

PRGO has a beta of 0.94, meaning it tends to be less sensitive to market movements. PRGO has a correlation of 0.09 to the broad based SPY ETF.

PRGO has a market cap of $1.34 billion. This is considered a Small Cap stock.

Last quarter Perrigo Company PLC reported $1 billion in Revenue and $.77 earnings per share. This beat revenue expectation by $43 million and missed earnings estimates by -$.02.

In the last 3 years, PRGO traded as high as $40.28 and as low as $9.23.

The top ETF exchange traded funds that PRGO belongs to (by Net Assets): IJR, VTI, VB, VBR, PEY.

PRGO has underperformed the market in the last year with a price return of -59.5% while the SPY ETF gained +22.6%. PRGO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -23.8% and -22.6%, respectively, while the SPY returned -1.6% and -2.5%, respectively.

PRGO support price is $9.05 and resistance is $9.55 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRGO shares will trade within this expected range on the day.